Nils Elander

Roger Olofsson Bagge, Axel Nelson, Amir Shafazand, Charlotta All-Eriksson, Christian Cahlin, Nils Elander, Hildur Helgadottir, Jens Folke Kiilgaard, Sara Kinhult, Ingrid Ljuslinder, Jan Mattsson, Magnus Rizell, Malin Sternby Eilard, Gustav J. Ullenhag, Jonas A. Nilsson, Lars Ny, Per Lindner (2023) Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial) Journal of Clinical Oncology, Vol. 41, p. 3042-+

Mustafa Asowed, Nils Elander, Linn Pettersson, Maria Ekholm, Dimitrios Papantoniou (2023) Activity and safety of KEES-an oral multi-drug chemo-hormonal metronomic combination regimen in metastatic castration-resistant prostate cancer BMC Cancer, Vol. 23, Article 309

Sander Ellegård, Kristina Engvall, Mustafa Asowed, Anna-Lotta Hallbeck, Nils Elander, Olle Stål (2022) Long-term follow-up of early stage HER2-positive breast cancer patients treated with trastuzumab: A population-based real world multicenter cohort study Frontiers in Oncology, Vol. 12

Ylva Naeser, Hildur Helgadottir, Johan Hansson, Christian Ingvar, Nils Elander, Petra Flygare, Cecilia Nilsson, Frida Jakobsson, Antonios Valachis, Dimitrios Papantoniou, Agneta Nordin Danfors, Hemming Johansson, Anders Sundin, Yvonne Brandberg, Gustav J. Ullenhag (2022) Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study) Cancers, Vol. 14

Jenny Isaksson, Henrik Green, Dimitrios Papantoniou, Linn Pettersson, Mats Anden, Johan Rosell, Elisabeth Åvall Lundqvist, Nils Elander (2021) Real-world evaluation of upfront docetaxel in metastatic castration-sensitive prostate cancer World Journal of Clinical Oncology, Vol. 12, p. 1009-1022

Publications